WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4301 Infant (under 12 months) mortality rate: 432
GDP / capita (US$): 9781 Child (under 5 years) mortality rate: 622

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 22'294  21'679  21'080  20'496  19'927  15'745  11'546  8'747 
Births 781  765  749  735  722  648  524  389 
Surviving infants 751  735  719  704  690  604  469  345 
Pop. less than 5 years 3'529  3'454  3'381  3'316  3'254  2'841  2'113  1'647 
Pop. less than 15 years 9'529  9'341  9'150  8'966  8'778  7'164  5'211  4'054 
Female 15-49 years 5'317  5'143  4'976  4'813  4'658  3'609  2'627  1'915 

Number of reported case

(Click for retrospective incidence data for Madagascar)
Diphtheria 12  252  227 
Japanese encephalitis
Measles 35'256  14'459  119'679 
Mumps 12 
Pertussis 33  369  255  3'880  1'333  32'457 
Polio* 39  68 
Rubella 110  196  157  193  73 
Rubella (CRS)
Tetanus (neonatal) 43  13  208 
Tetanus (total) 490  728  212  227  54  208  842 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Madagascar)
Vaccine year result method % card seen                                                
BCG 2010  76  EPI   56.1  78  82  81  87  97  99*  98  21 
DTP1 2010  92  EPI   56.1  97  96  94  96  100  86 
DTP3 2010  82  EPI   56.1  86  89  85  89  88  80  71  48 
HepB_BD         
HepB3 2010  82  EPI   56.1  86  89  85  89  88 
Hib3 2010  82  EPI   56.1  86  89  85  89  52 
JapEnc         
MCV 2010  73  EPI   56.1  85  85  88  85  91  81  57 
MCV2         
PCV1          65 
PCV3         
Pol3 2010  80  EPI   56.1  86  88  85  89  90  81  69 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  80  EPI   56.1  59  62  58  61  64  40  31 
PAB         
VAD1          91  93  100 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Madagascar)
BCG 78  82  81  80  83  72  67  21 
DTP1 96  96  94  88  84  74  71 
DTP3 86  89  85  83  77  57  46 
HepB3 86  89  85  83  80 
Hib3 86  89  85  83  52 
MCV 69  70  73  67  70  57  47 
PAB 78  78  76  76  76  58  45 
PCV3
Pol3 86  88  85  82  77  58  46 
Rota_last

Number of districts in the country 112  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 27
From 50 to 79% 31
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From January 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2010-2014  2007-2011    2003-2007 
Nº of districts with microplans that include activities to raise immunization coverage number 112  112  111  111  111  111  88 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  Yes  No         

System performance

Total number of districts in country number 112  112  111  111  111  111  111 
Nº districts with DTP3 coverage >=80% number 76  86  65  76  78  84  80 
% of districts with DTP3 coverage >=80% From 0 to 100% 68  77  59  68  70  76  72 
Nº districts with measles (MCV1) coverage >=95% number 25  21  41  30  44     
% of districts with MCV1 coverage >=95% From 0 to 100% 22  19  37  27  40     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 21  8,54% Yes tous les vaccins et 51% Yes vaccins traditionnels  10  26  18 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.